Thrivent Financial for Lutherans’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.16M | Sell |
|
|||||
|
2025
Q2 | $3.1M | Sell |
|
|||||
|
2025
Q1 | $5.21M | Sell |
|
|||||
|
2024
Q4 | $11.5M | Sell |
|
|||||
|
2024
Q3 | $15.4M | Sell |
|
|||||
|
2024
Q2 | $113M | Sell |
|
|||||
|
2024
Q1 | $172M | Sell |
|
|||||
|
2023
Q4 | $145M | Buy |
|
|||||
|
2023
Q3 | $94.9M | Buy |
|
|||||
|
2023
Q2 | $47.9M | Buy |
|
|||||
|
2023
Q1 | $45.9M | Sell |
|
|||||
|
2022
Q4 | $70.2M | Sell |
|
|||||
|
2022
Q3 | $77M | Buy |
|
|||||
|
2022
Q2 | $78.7M | Sell |
|
|||||
|
2022
Q1 | $94.6M | Buy |
|
|||||
|
2021
Q4 | $92M | Buy |
|
|||||
|
2021
Q3 | $64.5M | Sell |
|
|||||
|
2021
Q2 | $75.3M | Buy |
|
|||||
|
2021
Q1 | $58M | Buy |
|
|||||
|
2020
Q4 | $55.4M | Buy |
|
|||||
|
2020
Q3 | $50.8M | Buy |
|
|||||
|
2020
Q2 | $47.5M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $201 | Buy |
|